NCT06617585Not yet recruiting
The Role of CircDENND4C in Epithelial Ovarian Cancer
Source: ClinicalTrials.gov · Last updated 27 Sept 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
circular RNAs (circRNAs), a newly discovered type of endogenous noncoding RNAs \[8\], are involved in the regulation of various biological functions. They act by sponging off certain microRNAs (miRNAs) and play a role in the pathogenesis of many diseases, including cancers \[9-11\]. In addition, circRNAs are not com- monly degraded by RNA enzymes present in body flu- ids \[8\], and most of them possess expression specificity at the tissue, cell, and developmental stage level \[12,13\]. Thus, they can be ideal clinica
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 27 Nov 2023
- Start date
- 1 Dec 2024
- Primary completion date
- 2 Feb 2028
- Lead sponsor
- Assiut University
- Diseases
- Ovarian cancer
- NCT number
- NCT06617585
What you commit to
- Study type: Observational
- Planned participants: 30
- From 1 Dec 2024 to the primary completion date, 2 Feb 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- . Patients receive any anti-cancer therapy. 2. Patients diagnosed with other concomitante cancer or chronic disease
Who the study is looking for
- \- patients at South Egypt Cancer institute and Recently diagnosed ovarian cancer patients 2. Patients not went to surgery.
Age in the registry: 18 years to 75 years · Sex: Female · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.